New cure strategies for Hepatitis B are in development. Emerging data suggests a key role for biomarkers to identify subsets of people living with Hepatitis B who are most likely to respond to treatment. In this webinar, we discussed recent advances in Hepatitis B biomarker development, and how these tools can be used to personalise the management of people living with Hepatitis B.
Is Hepatitis B entering the era of personalised medicine?
Dapatkan kabar dan info terbaru dari LabInsights
![](https://labinsights.com/wp-content/uploads/2024/08/subscribe_banner_img_mobile.jpg)
Lainnya dalam topik yang sama
Get subscribe to Lab Insights latest news and update
![](https://labinsights.com/wp-content/uploads/2024/08/subscribe_banner_img_mobile.jpg)
Bacaan Berikutnya
- C-Suite Perspectives, Event Coverage, Healthcare Transformation, Management, RED 2024
- C-Suite Perspectives, Leaders In Conversation, Management
- Healthcare Transformation, Management, Operations, Population Health Management
- Disease Area, Healthcare Transformation, Histopathology, Leaders In Conversation, Management, Oncology, Operations